Skip to Content
Merck

Key Documents

View All Documentation

V800244

Magnesium sulfate heptahydrate

LR, ≥99%

Synonym(s):

Epsom salts

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
MgSO4 · 7H2O
CAS Number:
10034-99-8
Molecular Weight:
246.47
UNSPSC Code:
12352302
PubChem Substance ID:
329829245
EC Number:
231-298-2
MDL number:
MFCD00149785
Assay:
≥99%
Grade:
LR
Form:
crystalline powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

LR

vapor density

<0.01 (vs air)

product line

Vetec™

assay

≥99%

form

crystalline powder

pH

5.0-8.2 (5% in water)

SMILES string

O.O.O.O.O.O.O.[Mg++].[O-]S([O-])(=O)=O

InChI

1S/Mg.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2

InChI key

WRUGWIBCXHJTDG-UHFFFAOYSA-L

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

Still not finding the right product?

Explore all of our products under Magnesium sulfate heptahydrate

Storage Class

13 - Non Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ran D Goldman et al.
Pediatrics, 132(6), e1634-e1641 (2013-11-28)
Vaso-occlusive episodes (VOEs) are the most common complication of sickle cell disease in children. Treatment with magnesium seems to improve cellular hydration and may result in reduced vaso-occlusion. This study aimed to determine if intravenous (IV) magnesium sulfate (MgSO4) reduces
D H Salinger et al.
BJOG : an international journal of obstetrics and gynaecology, 120(7), 894-900 (2013-03-28)
To compare magnesium sulphate concentrations achieved by intramuscular and intravenous regimens used for the prevention of eclampsia. Low-resource obstetric hospitals in Nagpur and Vellore, India. Pregnant women at risk for eclampsia due to hypertensive disease. A pharmacokinetic study was performed
Karen J Gibbins et al.
Obstetrics and gynecology, 121(2 Pt 1), 235-240 (2013-01-25)
Clinical trials support the efficacy and safety of magnesium sulfate for cerebral palsy prevention. We evaluated the implementation of a clinical protocol for the use of magnesium for cerebral palsy prevention in our large women's hospital, focusing on uptake, indications
View All Related Papers

Global Trade Item Number

SKUGTIN
V800244-500G04061832761275